These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2952268)

  • 41. D-1 dopamine receptor stimulation elevates plasma prolactin levels.
    Saller CF; Salama AI
    Eur J Pharmacol; 1986 Mar; 122(1):139-42. PubMed ID: 3007174
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dopamine D-1 receptor agonist stimulation of prolactin secretion in man.
    Fabbrini G; Braun A; Mouradian MM; Tamminga CA; Chase TN
    J Neural Transm; 1988; 71(3):159-63. PubMed ID: 2965754
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional and binding studies on dopamine D1 receptors in districts controlling intraocular pressure.
    Daniele E; Govoni S; Lograno MD
    Pharmacol Res; 1990; 22 Suppl 1():55-6. PubMed ID: 2284248
    [No Abstract]   [Full Text] [Related]  

  • 44. Effect of a dopamine D-1 agonist in rats treated chronically with zuclopenthixol.
    Glenthøj B; Arnt J; Hyttel J
    Life Sci; 1990; 47(15):1339-46. PubMed ID: 2146458
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Localisation of striatal muscarinic receptors involved in dopamine receptor-mediated behavioural responses.
    Crocker AD; Cameron DL
    Neurosci Lett; 1992 Aug; 142(1):73-6. PubMed ID: 1407723
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Behavioural correlates of the action of selective D-1 dopamine receptor antagonists. Impact of SCH 23390 and SKF 83566, and functionally interactive D-1:D-2 receptor systems.
    Waddington JL
    Biochem Pharmacol; 1986 Nov; 35(21):3661-7. PubMed ID: 3535801
    [No Abstract]   [Full Text] [Related]  

  • 47. SKF 38393: vacillatory behavior in immature rats.
    Molino LJ; Shemer A; Whitaker-Azmitia PM
    Eur J Pharmacol; 1989 Feb; 161(2-3):223-5. PubMed ID: 2566489
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A photoaffinity label for the D-1 dopamine receptor, (RS)-7-[125I]Iodo-8-hydroxy-3-methyl-1-(4'-azidophenyl)-2,3,4,5- tetrahydro-1H-3-benzazepine, selectively identifies the ligand binding subunits of the receptor.
    Baindur N; Neumeyer JL; Niznik HB; Bzowej NH; Jarvie KR; Seeman P; Garlick RK; Miller JJ
    J Med Chem; 1988 Nov; 31(11):2069-71. PubMed ID: 3263503
    [No Abstract]   [Full Text] [Related]  

  • 49. The effects of two stressors on working memory and cognitive flexibility in zebrafish (Danio rerio): The protective role of D1/D5 agonist on stress responses.
    Fontana BD; Cleal M; Gibbon AJ; McBride SD; Parker MO
    Neuropharmacology; 2021 Sep; 196():108681. PubMed ID: 34175323
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Renal vascular activity of SK&F 38393 and dopamine in anesthetized dogs.
    Hahn RA; Wardell JR
    J Cardiovasc Pharmacol; 1980; 2(5):583-93. PubMed ID: 6157951
    [No Abstract]   [Full Text] [Related]  

  • 51. Are D1 dopamine receptor agonists potential antidepressants?
    Serra G; Collu M; D'Aquila P; Pani L; Gessa GL
    Pharmacol Res Commun; 1988 Dec; 20(12):1121-2. PubMed ID: 2905479
    [No Abstract]   [Full Text] [Related]  

  • 52. Dopamine D-1 and D-2 receptors in relation to reward and performance: a case for the D-1 receptor as a primary site of therapeutic action of neuroleptic drugs.
    Miller R; Wickens JR; Beninger RJ
    Prog Neurobiol; 1990; 34(2):143-83. PubMed ID: 1969668
    [No Abstract]   [Full Text] [Related]  

  • 53. The multiplicity of the D1 dopamine receptor.
    Mailman RB; Schulz DW; Kilts CD; Lewis MH; Rollema H; Wyrick S
    Adv Exp Med Biol; 1986; 204():53-72. PubMed ID: 2947430
    [No Abstract]   [Full Text] [Related]  

  • 54. Relevance of the rodent area postrema to dopamine-dependent behavioural effects.
    Costall B; Fortune DH; Naylor RJ
    J Pharm Pharmacol; 1981 Apr; 33(4):257-9. PubMed ID: 6115916
    [No Abstract]   [Full Text] [Related]  

  • 55. Renal dopamine-1 defect in spontaneous hypertension.
    Felder RA; Seikaly MG; Eisner GM; Jose PA
    Contrib Nephrol; 1988; 67():71-4. PubMed ID: 3264779
    [No Abstract]   [Full Text] [Related]  

  • 56. 6-(Phenylthio)-substituted 2,3,4,5-tetrahydro-1H-3-benzazepines, a novel class of dopamine receptor antagonists and neuroleptics.
    Kaiser C; Ali FE; Bondinell WE; Brenner M; Holden KG; Ku TW; Oh HJ; Ross ST; Yim NC; Zirkle CL; Hahn RA; Sarau HM; Setler PE; Wardell JR
    J Med Chem; 1980 Sep; 23(9):975-6. PubMed ID: 6106062
    [No Abstract]   [Full Text] [Related]  

  • 57. Neostriatal dopamine receptor loss and behavioral deficits in the senescent rat.
    Cubells JF; Joseph JA
    Life Sci; 1981 Mar; 28(11):1215-8. PubMed ID: 7194955
    [No Abstract]   [Full Text] [Related]  

  • 58. Separation of potent central and renal dopamine agonist activity in substituted 6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepines.
    Weinstock J; Wilson JW; Ladd DL; Brush CK; Pfeiffer FR; Kuo GY; Holden KG; Yim NC; Hahn RA; Wardell JR; Tobia AJ; Setler PE; Sarau HM; Ridley PT
    J Med Chem; 1980 Sep; 23(9):973-5. PubMed ID: 7411552
    [No Abstract]   [Full Text] [Related]  

  • 59. Normal and abnormal determinants of dopamine receptor ontogeny in the central nervous system.
    Feigenbaum JJ; Yanai J
    Prog Neurobiol; 1984; 23(3):191-225. PubMed ID: 6240665
    [No Abstract]   [Full Text] [Related]  

  • 60. The Yawning elicited by alpha-melanocyte-stimulating hormone involves serotonergic-dopaminergic-cholinergic neuron link in rats.
    Yamada K; Furukawa T
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Apr; 316(2):155-60. PubMed ID: 6972489
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.